National Bank of Canada
UTHR icon

National Bank of Canada’s United Therapeutics UTHR Stock Holding History

National Bank of Canada’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Buy
905
+124
+16% +$69.8K ﹤0.01% 1445
2026
Q1 		$464K Sell
781
-7,051
-90% -$3.51M ﹤0.01% 1409
2025
Q4 		$3.82M Buy
7,832
+7,552
+2,697% +$3.52M ﹤0.01% 928
2025
Q3 		$117K Buy
280
+17
+6% +$5.72K ﹤0.01% 1713
2025
Q2 		$75.6K Buy
263
+91
+53% +$27.2K ﹤0.01% 1862
2025
Q1 		$53K Sell
172
-2
-1% -$685 ﹤0.01% 1867
2024
Q4 		$61.5K Buy
174
+12
+7% +$4.41K ﹤0.01% 1879
2024
Q3 		$58K Sell
162
-24
-13% -$8.11K ﹤0.01% 1669
2024
Q2 		$59.3K Sell
186
-33
-15% -$8.73K ﹤0.01% 1638
2024
Q1 		$57.9K Sell
219
-21,312
-99% -$4.81M ﹤0.01% 1707
2023
Q4 		$4.89M Sell
21,531
-19,637
-48% -$4.53M 0.01% 774
2023
Q3 		$9.15M Buy
41,168
+23,956
+139% +$5.52M 0.01% 629
2023
Q2 		$3.85M Buy
17,212
+12,936
+303% +$2.87M 0.01% 796
2023
Q1 		$963K Buy
4,276
+4,071
+1,986% +$1M ﹤0.01% 1069
2022
Q4 		$57K Sell
205
-3,719
-95% -$939K ﹤0.01% 1704
2022
Q3 		$839K Buy
3,924
+3,764
+2,353% +$841K ﹤0.01% 1033
2022
Q2 		$38K Sell
160
-5,982
-97% -$1.22M ﹤0.01% 1842
2022
Q1 		$1.1M Buy
6,142
+6,000
+4,225% +$1.14M ﹤0.01% 1065
2021
Q4 		$31K Buy
+142
New +$27.9K ﹤0.01% 2040

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

National Bank of Canada's UTHR Position: Q2 2026 in Review

National Bank of Canada increased its United Therapeutics (UTHR) stake by 16% in Q2 2026, buying an estimated $69.8K and bringing the position to 905 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

National Bank of Canada first reported a position in UTHR in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.15M in Q3 2023. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • National Bank of Canada held 905 shares of United Therapeutics worth $491K as of Q2 2026.
  • National Bank of Canada bought 124 United Therapeutics shares in Q2 2026, an estimated $69.8K.
  • United Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #1445 holding.
  • National Bank of Canada first reported a position in United Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's United Therapeutics position peaked at $9.15M in Q3 2023.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.